Exodus Movement Inc EXOD Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Data Unavailable NAUT Q1 2026 Earnings EPS Beat of 1886 Reflects Cost Discipline Amid PreRevenue Phase Atossa Therapeutics Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances SFNC Q1 2026 Earnings Narrow EPS Miss and Flat Stock Reaction Amid Steady Operations Lifevantage Corporation LFVN Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction PKOH Q1 2026 Earnings Narrow EPS Miss as Stock Rises 277